Kidney Injury Molecule-1 and Cardiovascular Diseases: From Basic Science to Clinical Practice

Branislava Medić1, Branislav Rovčanin2, Gordana Basta Jovanović3

  • 1Department of Pharmacology, Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Belgrade, Dr Subotica Starijeg 1, 11129 Belgrade, Serbia.

Insights

Kidney injury molecule-1 (KIM-1) shows promise for early detection of cardiovascular disease risk in patients with kidney problems. Monitoring KIM-1 may improve outcomes for those with cardiorenal conditions.

Area of Science:

  • Nephrology
  • Cardiology
  • Biomarker Discovery

Background:

  • Cardiovascular disease (CVD) is a leading cause of death in patients with kidney dysfunction, particularly acute kidney injury (AKI).
  • Early identification of patients with combined renal and cardiovascular risk is crucial for timely intervention and improved outcomes.
  • Kidney Injury Molecule-1 (KIM-1) is emerging as a significant biomarker for kidney damage.

Purpose of the Study:

  • To review current literature on KIM-1's role in the early diagnosis and prognosis of cardiovascular diseases.
  • To highlight KIM-1's potential as a predictive marker in cardiorenal conditions.

Main Methods:

  • Literature review of animal and human studies on KIM-1.
  • Analysis of KIM-1's established role in acute tubular necrosis (ATN) and AKI prediction.
  • Exploration of KIM-1's relevance in cardiorenal syndromes and related cardiovascular conditions.

Main Results:

  • KIM-1 is recognized as a key marker for acute tubular necrosis (ATN) and a predictor of AKI development and prognosis.
  • The US FDA has approved KIM-1 as an AKI biomarker for preclinical drug development.
  • Emerging data underscore KIM-1's importance in monitoring various renal diseases and cardiovascular conditions, including cardiorenal syndrome and heart failure.

Conclusions:

  • KIM-1 is a promising biomarker for the early diagnosis and prediction of clinical outcomes in specific cardiovascular diseases.
  • Further research into KIM-1 monitoring could enhance patient management in cardiorenal settings.

Related Concept Videos

Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
1.9K
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
1.2K
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
482
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
945
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.4K
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
463